- Home
- MBBC vs OVID Comparison
MBBC vs OVID Comparison
Compare MBBC & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBBC
- OVID
- Stock Information
- Founded
- MBBC 1902
- OVID 2014
- Country
- MBBC United States
- OVID United States
- Employees
- MBBC N/A
- OVID N/A
- Industry
- MBBC Banks
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- MBBC Finance
- OVID Health Care
- Exchange
- MBBC Nasdaq
- OVID Nasdaq
- Market Cap
- MBBC 22.1M
- OVID 20.6M
- IPO Year
- MBBC N/A
- OVID 2017
- Fundamental
- Price
- MBBC $10.04
- OVID $0.31
- Analyst Decision
- MBBC
- OVID Strong Buy
- Analyst Count
- MBBC 0
- OVID 4
- Target Price
- MBBC N/A
- OVID $3.13
- AVG Volume (30 Days)
- MBBC 9.6K
- OVID 969.8K
- Earning Date
- MBBC 05-14-2025
- OVID 08-12-2025
- Dividend Yield
- MBBC N/A
- OVID N/A
- EPS Growth
- MBBC 103.56
- OVID N/A
- EPS
- MBBC 0.22
- OVID N/A
- Revenue
- MBBC $6,591,743.00
- OVID $548,000.00
- Revenue This Year
- MBBC N/A
- OVID N/A
- Revenue Next Year
- MBBC N/A
- OVID $5.32
- P/E Ratio
- MBBC $45.59
- OVID N/A
- Revenue Growth
- MBBC N/A
- OVID 15.61
- 52 Week Low
- MBBC $6.05
- OVID $0.24
- 52 Week High
- MBBC $12.00
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- MBBC N/A
- OVID 52.32
- Support Level
- MBBC N/A
- OVID $0.29
- Resistance Level
- MBBC N/A
- OVID $0.32
- Average True Range (ATR)
- MBBC 0.00
- OVID 0.03
- MACD
- MBBC 0.00
- OVID 0.00
- Stochastic Oscillator
- MBBC 0.00
- OVID 50.50
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.